ENOX2 Target for the Anticancer Isoflavone ME-143

ME-143 (NV-143), a synthetic isoflavone under clinical evaluation for efficacy in the management of ovarian and other forms of human cancer, blocked the activity of a cancer-specific and growth-related cell surface ECTO-NOX protein with both oxidative (hydroquinone) and protein disulfide-thiol inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Morré, D. James, Korty, Theodore, Meadows, Christiaan, Ades, Laura M. C., Morré, Dorothy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592813/
https://www.ncbi.nlm.nih.gov/pubmed/25700353
http://dx.doi.org/10.3727/096504014X14077751730270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592813/
https://www.ncbi.nlm.nih.gov/pubmed/25700353
http://dx.doi.org/10.3727/096504014X14077751730270

Ejemplares similares